Related Topics News -

     
 Title only   |   Print 
     
中生製藥貝莫蘇拜單抗聯合安羅替尼新適應症獲批上市

2026-04-20T  
中國生物製藥創新藥MK-2010/LM-299公布初步臨床數據

2026-04-19T  
中生製藥維特柯妥拜單抗胃癌III期臨床試驗完成首例患者入組

2026-04-15T  
國家藥監局:持續推進仿製藥一致性評價工作 已遴選發布103批參比製劑

2026-04-15T  
《大行》大摩升中生製藥目標價至8.3元 評級「增持」

2026-04-13T  
中國生物製藥附屬創新藥Kylo-11已完成美國首例患者入組

2026-04-10T  
中生製藥:創新藥納地美定獲批大灣區上市

2026-04-09T  
中國生物製藥創新藥TQB3205臨床試驗申請獲批

2026-04-09T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.